Structure

InChI Key UOZODPSAJZTQNH-LSWIJEOBSA-N
Smile NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3N)[C@@H]2O)[C@H](N)[C@@H](O)[C@@H]1O
InChI
InChI=1S/C23H45N5O14/c24-2-7-13(32)15(34)10(27)21(37-7)41-19-9(4-30)39-23(17(19)36)42-20-12(31)5(25)1-6(26)18(20)40-22-11(28)16(35)14(33)8(3-29)38-22/h5-23,29-36H,1-4,24-28H2/t5-,6+,7+,8-,9-,10-,11-,12+,13-,14-,15-,16-,17-,18-,19-,20-,21-,22-,23+/m1/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C23H45N5O14
Molecular Weight 615.63
AlogP -8.86
Hydrogen Bond Acceptor 19.0
Hydrogen Bond Donor 13.0
Number of Rotational Bond 9.0
Polar Surface Area 347.32
Molecular species BASE
Aromatic Rings 0.0
Heavy Atoms 42.0

Pharmacology

Targets EC50(nM) IC50(nM) Kd(nM) Ki(nM) Inhibition(%)
Enzyme Transferase
- - - - 29-60
Other cytosolic protein
- 38 - - 80
Unclassified protein
- 38 - - -

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Leishmaniasis, Visceral 3 D007898 ClinicalTrials
Leishmaniasis, Cutaneous 3 D016773 ClinicalTrials
Leishmaniasis 2 D007896 ClinicalTrials
Osteomyelitis 0 D010019 ClinicalTrials

Related Entries

MCS

Scaffolds

Salt

Cross References

Resources Reference
CAS NUMBER 7542-37-2
ChEBI 7934
ChEMBL CHEMBL370143
DrugBank DB01421
DrugCentral 2067
EPA CompTox DTXSID8023424
FDA SRS 61JJC8N5ZK
Human Metabolome Database HMDB0015490
KEGG C00832
PDB PAR
PharmGKB PA164784023
PubChem 165580
SureChEMBL SCHEMBL4072
ZINC ZINC000060183170